Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats

This publication has 24 references indexed in Scilit:

• The Effects of Central and Peripheral Angiotensin on Hypertension and Nociception in Rats
  Pharmacology Biochemistry and Behavior, 1997
• An Appraisal of the Pharmacological and Toxicological Effects of a Single Oral Administration of 3,4‐Methylenedioxymethamphetamine (MDMA) in the Rat
  Basic & Clinical Pharmacology & Toxicology, 1997
• Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion
  Biochemical Pharmacology, 1996
• Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing
  Physiology & Behavior, 1995
• The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype
  British Journal of Pharmacology, 1995
• Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")
  The Lancet, 1992
• Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat
  Pharmacology Biochemistry and Behavior, 1991
• Characterization of the common genetic defect in humans deficient in debrisoquine metabolism
  Nature, 1988
• 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA
  JAMA, 1987
• Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strains
  Journal of Pharmacy and Pharmacology, 1981